|
MSF Field Research >
1 Published Research and Commentary >
TB >
Ambulatory Multi-Drug Resistant Tuberculosis Treatment Outcomes in a Cohort of HIV-Infected Patients in a Slum Setting in Mumbai, India.
Please use
this identifier to cite or link
to this item:
http://hdl.handle.net/10144/198809
 Del.icio.us
 LinkedIn
 Citeulike
 Connotea
 Facebook
 Stumble it!
| Download this article: |
| View/Open |
File |
Description |
Size |
Format |
View/Open | Isaakidis MDR TB in Mumbai PLoS One.pdf | | 210Kb | Adobe PDF |
|
| Title: | Ambulatory Multi-Drug Resistant Tuberculosis Treatment Outcomes in a Cohort of HIV-Infected Patients in a Slum Setting in Mumbai, India. |
| Authors: | Isaakidis, Petros
Cox, Helen S
Varghese, Bhanumati
Montaldo, Chiara
Da Silva, Esdras
Mansoor, Homa
Ladomirska, Joanna
Sotgiu, Giovanni
Migliori, Giovanni B
Pontali, Emanuele
Saranchuk, Peter
Rodrigues, Camilla
Reid, Tony |
| Affiliation: | Médecins Sans Frontières, Mumbai, India. |
| Citation: | Ambulatory Multi-Drug Resistant Tuberculosis Treatment Outcomes in a Cohort of HIV-Infected Patients in a Slum Setting in Mumbai, India. 2011, 6 (12):e28066 PLoS ONE |
| Journal: | PloS One |
| Issue Date: | Dec-2011 |
| URI: | http://hdl.handle.net/10144/198809 |
| DOI: | 10.1371/journal.pone.0028066 |
| PubMed ID: | 22145022 |
| Abstract: | India carries one quarter of the global burden of multi-drug resistant TB (MDR-TB) and has an estimated 2.5 million people living with HIV. Despite this reality, provision of treatment for MDR-TB is extremely limited, particularly for HIV-infected individuals. Médecins Sans Frontières (MSF) has been treating HIV-infected MDR-TB patients in Mumbai since May 2007. This is the first report of treatment outcomes among HIV-infected MDR-TB patients in India. |
| Language: | en |
| ISSN: | 1932-6203 |
| Rights: | Published by Public Library of Science, http://www.plosone.org/
Archived on this site by Open Access permission |
| Appears in topics: | TB
|
| Related articles on PubMed |  | Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India.Isaakidis P, Varghese B, Mansoor H, Cox HS, Ladomirska J, Saranchuk P, Da Silva E, Khan S, Paryani R, Udwadia Z, Migliori GB, Sotgiu G, Reid T 2012 |
| | | | Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.Tabarsi P, Chitsaz E, Tabatabaei V, Baghaei P, Shamaei M, Farnia P, Marjani M, Kazempour M, Mansouri D, Masjedi MR, Velayati AA 2011 Sep |
| | Ambulatory-based standardized therapy for multi-drug resistant tuberculosis: experience from Nepal, 2005-2006.Malla P, Kanitz EE, Akhtar M, Falzon D, Feldmann K, Gunneberg C, Jha SS, Maharjan B, Prasai MK, Shrestha B, Verma SC, Zignol M 2009 Dec 23 |
| | See all 295 articles |
All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.
|
